Evotec Investor
Evotec is a drug discovery alliance company providing drug discovery solutions to pharmaceutical and biotechnology companies.
.jpg)
.png)
Total Funding:
733436691.0
Acquisitions Number:
Made Acquisitions
Headquarters:
Hamburg, Hamburg, Germany
Funding Status:
IPO
Employee Number:
1001-5000
Estimated Revenue:
$100M to $500M
Last Funding Type:
Post-IPO Debt
Number Of Exists:
2
Technology:
Biopharma, Biotechnology, Pharmaceutical
Investor Type:
Not Classified
Last Funding Date:
2023-02-10
Investors Number:
10.0
Founded Date:
1993-01-01
Industry:
End-to-End Drug Development